Alpha-1 Anti-Trypsin (AAT) Treatment in Acute Myocardial Infarction
Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
Acute myocardial infarction is characterized by an intense inflammatory response.
The degree of the response influences clinical outcome, with 'more' inflammation promoting
heart failure. In this study we plan to determine whether treatment with plasma derived
alpha-1 antitrypsin will quench the inflammatory response in patients with acute ST-segment
elevation myocardial infarction (STEMI).